ABATTIS BIOCEUTICALS (ATTBF)

0.084 -0.006 ( -6.770% ) 16

Instant Analysis On Any Stock…

Your Marijuana Trend Report Is Ready!

 

Instant Analysis On Any Stock…

Your Marijuana Trend Report Is Ready!

 

ATTBF Detailed Quote

Last Trade:   0.084
Trade Time:   12:58pm
Change:   -0.006
Perc Change:   -6.770%
Prev Close:   0.090
Open:   0.099
Day's Range:   0.082 - 0.099
Bid:   N/A
EPS   -0.022
52wk Range:   0.015 - 1.000
Volume:   132660
Avg Vol:   275516
Market Cap:   11.35M
P/E (ttm):   N/A
PES (ttm):   -0.022
Ask:   N/A

ATTBF Recent Headlines

  • Abattis Announces Vergence Update 08/15/2017 03:19 PMVancouver, British Columbia--(Newsfile Corp. - August 15, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to provide an update on its wholly-owned subsidiary, Vergence Visionary Bioceuticals ("Vergence"), which is a nutraceutical marketing and brand specialist firm focused on bringing innovative health products to market.New Brand PartnershipsVergence has recently signed an agreement to distribute Jonny Hetherington Essentials, a line of all-natural hot sauce and ketchup products. Made entirely from ingredients ...
  • Abattis Adds New Product Line to Wholly-Owned Subsidiary Vergence Naturals Distribution Portfolio 08/11/2017 01:18 PMVancouver, British Columbia--(Newsfile Corp. - August 11, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF) (the "Company" or "Abattis") is pleased to announce it has reached a deal with Jonny Hetherington Essentials for major distribution of their products throughout North America and potentially Asia, through its wholly-owned subsidiary, Vergence Visionary Bioceuticals ("Vergence" or "Vergence Naturals").The agreement with Jonny Hetherington Essentials, has the potential to bring immediate additional cash flow to Abattis and Vergence. ...
  • Abattis Files Amended and Restated Financial Statements For the Period Ended March 31, 2017 08/10/2017 01:02 AMVancouver, British Columbia--(Newsfile Corp. - August 9, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") announces that, as a result of a review by the British Columbia Securities Commission, we are issuing the following press release to clarify our disclosure.The review identified certain discrepancies in our condensed consolidated financial statements for the three and six months ended March 31, 2017 (the "Financial Statements"). As a result, we have amended ...
  • Abattis Expands and Strengthens Its Asian Distribution Sales Channels 07/25/2017 12:45 PMVancouver, British Columbia--(Newsfile Corp. - July 25, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce the appointment of Mr. Wei Ma to oversee export and business development in Asia, in an effort to further expand and strengthen the Company's Asian distribution channels.Mr. Ma has over 15 years of experience in international trade, with a focus on importing and exporting in Asia. His deep understanding and ...
  • Abattis Obtains DTC Eligibility 07/17/2017 12:15 PMVancouver, British Columbia--(Newsfile Corp. - July 17, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce that it has obtained Depository Trust Company ("DTC") eligibility in the United States ("US"). The DTC is a stock depository and facilitates electronic trading in the US. When shares are DTC eligible, trades are completed electronically in a more cost effective and timely method for settlement. Shares that ...

FIND OUT HOW MUCH MOMENTUM IS DRIVING YOUR MARIJUANA STOCK!

AS SEEN ON
>>